Molecular, Morphological, and Functional Characterization of Corticotropin-Releasing Factor Receptor 1-Expressing Neurons in the Central Nucleus of the Amygdala
Open Access
- 22 May 2019
- journal article
- research article
- Published by Society for Neuroscience in eneuro
- Vol. 6 (3)
Abstract
The central nucleus of the amygdala (CeA) is a brain region implicated in anxiety, stress-related disorders and the reinforcing effects of drugs of abuse. Corticotropin-releasing factor (CRF,Crh)acting at cognate type 1 receptors (CRF1,Crhr1) modulates inhibitory and excitatory synaptic transmission in the CeA. Here, we used CRF1:GFP reporter mice to characterize the morphological, neurochemical and electrophysiological properties of CRF1-expressing (CRF1+) and CRF1-non-expressing (CRF1–) neurons in the CeA. We assessed these two neuronal populations for distinctions in the expression of GABAergic subpopulation markers and neuropeptides, dendritic spine density and morphology, and excitatory transmission. We observed that CeA CRF1+ neurons are GABAergic but do not segregate with calbindin (CB), calretinin (CR), parvalbumin (PV), or protein kinase C-δ (PKCδ). Among the neuropeptides analyzed,PenkandSsthad the highest percentage of co-expression withCrhr1in both the medial and lateral CeA subdivisions. Additionally, CeA CRF1+ neurons had a lower density of dendritic spines, which was offset by a higher proportion of mature spines compared to neighboring CRF1– neurons. Accordingly, there was no difference in basal spontaneous glutamatergic transmission between the two populations. Application of CRF increased overall vesicular glutamate release onto both CRF1+ and CRF1– neurons and does not affect amplitude or kinetics of EPSCs in either population. These novel data highlight important differences in the neurochemical make-up and morphology of CRF1+ compared to CRF1– neurons, which may have important implications for the transduction of CRF signaling in the CeA.Keywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism (AA021491, AA015566, AA006420, AA017447, AA026685, AA024952, AA026865, AA007456)
This publication has 83 references indexed in Scilit:
- Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in ratsPharmacology Biochemistry and Behavior, 2012
- Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: Evidence from animal modelsPharmacology & Therapeutics, 2010
- Genetic dissection of an amygdala microcircuit that gates conditioned fearNature, 2010
- Corticotropin Releasing Factor–Induced Amygdala Gamma-Aminobutyric Acid Release Plays a Key Role in Alcohol DependenceBiological Psychiatry, 2010
- The role of CRF and CRF-related peptides in the dark side of addictionBrain Research, 2010
- 30 years of dynorphins — New insights on their functions in neuropsychiatric diseasesPharmacology & Therapeutics, 2009
- Type 1 corticotropin‐releasing factor receptor expression reported in BAC transgenic mice: Implications for reconciling ligand‐receptor mismatch in the central corticotropin‐releasing factor systemJournal of Comparative Neurology, 2008
- A Role for Brain Stress Systems in AddictionNeuron, 2008
- Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockoutPharmacology Biochemistry and Behavior, 2007
- Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent RatsBiological Psychiatry, 2007